These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 660443)

  • 41. Self nano-emulsifying simvastatin based tablets: design and in vitro/in vivo evaluation.
    Abdelbary G; Amin M; Salah S
    Pharm Dev Technol; 2013; 18(6):1294-304. PubMed ID: 22468935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bioavailability of commercial chloramphenicol tablets in humans (author's transl)].
    Watanabe Y; Nagai T; Tanaka Y; Motoashi K
    Yakugaku Zasshi; 1975 May; 95(5):599-608. PubMed ID: 1171207
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the pharmaceutical technology of film coating (author's transl)].
    Kala H; Dittgen M; Moldenhauer H; Zessin G
    Pharmazie; 1979 Nov; 34(11):755-65. PubMed ID: 397492
    [No Abstract]   [Full Text] [Related]  

  • 44. [Enhancing of drug bioavailability using liquisolid system formulation].
    Gajdziok J; Vraníková B
    Ceska Slov Farm; 2015 Jun; 64(3):55-66. PubMed ID: 26400228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissolution systems for chloramphenicol tablet bioavailability.
    Ogata H; Shibazaki T; Inoue T; Ejima A
    J Pharm Sci; 1979 Jun; 68(6):712-5. PubMed ID: 37318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
    Van Gyseghem E; Pendela M; Baert L; Rosier J; Van 't Klooster G; De Man H; Bouche MP; Schueller L; Van Remoortere P; Wigerinck P; Adams E; Hoogmartens J; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Nov; 70(3):853-60. PubMed ID: 18657611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effervescent tablets--a nearly forgotten drug form].
    Schmidt PC; Christin I
    Pharmazie; 1990 Feb; 45(2):89-101. PubMed ID: 2187207
    [No Abstract]   [Full Text] [Related]  

  • 48. [Influence of adjuvants on the speed of dissolution and stability of acetylsalicylic acid in tablets. I. Effects of some disintegrating agents].
    Cid E; Jaminet F
    J Pharm Belg; 1971; 26(1):38-48. PubMed ID: 5559275
    [No Abstract]   [Full Text] [Related]  

  • 49. Interaction of tablet disintegrants and magnesium stearate during mixing. II. Effect on dissolution rate.
    Lerk CF; Bolhuis GK; Smallenbroek AJ; Zuurman K
    Pharm Acta Helv; 1982; 57(10-11):282-6. PubMed ID: 7146030
    [No Abstract]   [Full Text] [Related]  

  • 50. [On the compression behaviour of spray-dried sulphathiazole (author's transl)].
    Kala H; Moldenhauer H; Giese R; Kedvessy G; Selmeczi B; Pintye-Hódi K
    Pharmazie; 1982 Feb; 37(2):129-31. PubMed ID: 7071118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of pharmaceutical adjuvant on absorption of drugs. Effect of magnesium aluminosilicate on absorption of aspirin in man (author's transl)].
    Kitazawa S; Sakai K; Murasaki H
    Yakugaku Zasshi; 1974 Nov; 94(11):1353-7. PubMed ID: 4478161
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the production and the characterization of spray embeddings (author's transl)].
    Kala H; Traue J; Moldenhauer H; Zessin G
    Pharmazie; 1981; 36(2):106-11. PubMed ID: 7232480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Tableting of difficult to activate solids. Binding conditions in calcium hydrogen phosphate tablets].
    Hütenrauch R; Fricke S
    Pharmazie; 1978 Jun; 33(6):376. PubMed ID: 684059
    [No Abstract]   [Full Text] [Related]  

  • 54. [Studies on impact strength of tablets. II. Impact collision strength of tablets (author's transl)].
    Suwa K
    Yakugaku Zasshi; 1978 Jun; 98(6):696-700. PubMed ID: 690808
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies on impact strength of tablets. III. Impact load strength of tablets (author's transl)].
    Suwa K
    Yakugaku Zasshi; 1978 Jun; 98(6):701-7. PubMed ID: 690809
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experiments on particle separation in powders and its prevention by different types of cellulose (author's transl)].
    Graf E; Beyer C
    Arch Pharm (Weinheim); 1976 Feb; 309(2):107-19. PubMed ID: 938203
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proceedings: Effect of moisture content on the physical properties of a starch granulation.
    Cole ET; Elworthy PH; Sucker H
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():1P. PubMed ID: 2681
    [No Abstract]   [Full Text] [Related]  

  • 59. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations.
    Klueglich M; Ring A; Scheuerer S; Trommeshauser D; Schuijt C; Liepold B; Berndl G
    J Clin Pharmacol; 2005 Sep; 45(9):1055-61. PubMed ID: 16100300
    [No Abstract]   [Full Text] [Related]  

  • 60. [Studies on impact strength of tablets. I. Impact compression strength and impact bending strength of tablets (author's transl)].
    Suwa K
    Yakugaku Zasshi; 1978 May; 98(5):563-8. PubMed ID: 660425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.